Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis

Part of paid clinical trials in Houston, Texas.

Sponsor
Ali Chappell
Study ID
NCT05950282
Status
Recruiting
Apply to this trial

Conditions

  • Hyperinsulinism
  • Insulin Resistance
  • Metabolic Syndrome
  • Obesity
  • Polycystic Ovary Syndrome

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

The study aims to investigate the relationship between fasting insulin and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) across various demographic factors, including age, sex, race/ethnicity, BMI, and polycystic ovary syndrome (PCOS) diagnosis. By analyzing these variables, the study seeks to identify potential variations in insulin levels, which could provide valuable insights into the impact of different factors on metabolic health and the development of insulin-related conditions.

Key Dates

Start date
Feb 1, 2024
Status verified
Apr 2026
Primary completion
Oct 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
150 participants (estimated)

Primary Outcome Measure

Assessment of Fasting Insulin levels and HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) scores among different groups stratified by age, sex, race/ethnicity, BMI, and PCOS (Polycystic Ovary Syndrome) diagnosis. [ Time Frame: 3 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Lilli HealthHoustonTexas77554
Ali M Chappell, PhD, MS, RD
[email protected]
8064417275

Find similar trials in Houston, TX

By condition
Obesity / overweight
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
Lilli Health· Houston, TX

Related Studies